Preferences help
enabled [disable] Abstract
Number of results
2015 | 87 | 7 | 357-361
Article title

Evaluation Of Antioxidant Defense In Patients With Colorectal Carcinoma

Title variants
Languages of publication
Cancers are among the most feared diseases of modern civilization. In Poland, colorectal cancer is one of the tumors with the worst prognosis. The ability to cure is primarily dependent on the stage of the disease at the time of diagnosis.The aim of the study was evaluate antioxidant response in patients with colorectal carcinoma.Material and methods. Twenty patients (14 men and 6 women) aged 61.9± 11.1 years with colorectal cancer were included in the study. Twenty healthy subjects (4 men and 16 women) aged 64 ± 15.3 years formed the control group. The erythrocyte activities of antioxidant enzymes, superoxide dismutase (SOD), and glutathione peroxidase (GPx),Results. A significant increase of GPx, and SOD (p < 0.05) were seen in patients compared to healthy controls.Conclusion. The results indicate that the tested antioxidant enzyme activity of glutathione peroxidase and superoxide dismutase is increased in patients diagnosed with colorectal cancer compared to the control group.
GPx   SOD   colon cancer  
Physical description
1 - 7 - 2015
7 - 7 - 2015
7 - 9 - 2015
  • Department of Clinical Chemistry and Biochemistry, Medical University in ŁódźKierownik: prof. dr hab.
  • Department of General and Colorectal Surgery, Medical University in ŁódźKierownik: prof. dr hab.
  • Department of General and Colorectal Surgery, Medical University in ŁódźKierownik: prof. dr hab.
  • Department of General and Colorectal Surgery, Medical University in ŁódźKierownik: prof. dr hab.
  • Department of Clinical Chemistry and Biochemistry, Medical University in ŁódźKierownik: prof. dr hab.
  • 1. Mitura K, Kozieł S, Pasierbek M i wsp.: Leczenie przepuklin pachwinowych w północnej Ghanie. Pol Przegl Chir 2015; 1: 29-40.
  • 2. Tyczynski JE, Bray F, Aareleid et al.: Lung cancer mortality patterns in selected Central, Eastern and Southern European countries. Int J Cancer 2004; 109: 598-610.
  • 3. Akkooi AC, Nowecki ZI, Voit C et al.: Tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients 1 with positive sentinel nodes. Ann Surg 2008; 248: 949-55.
  • 4. Kubiak K, Malinowska K, Langner E i wsp.: Wpływ związków koordynacyjnych Cu(II) na aktywność enzymów antyoksydacyjnych katalazy i dysmutazy ponadtlenkowej u chorych na raka jelita grubego. Pol Przegl Chir 2011; 83: 282-92.
  • 5. Malinowska K, Modranka R: Wpływ związków chromonu na aktywność wybranych enzymów antyoksydacyjnych u chorych ograniczonych ruchowo. PML 2010; 163: 26-28.
  • 6. Kubiak K, Klimczak A, Dziki Ł: Synthesis and pro-antioxidant properties of Cu(II) complexes with pyrazole ligands. PML 2010;163: 22-25.
  • 7. Malinowska K, Misiak P, Modranka R i wsp.: Właściwości biologiczne kompleksu benzopiranu z Pt (II). Pol Przegl Chir 2014; 86(4): 299-311.
  • 8. Misiak P, Wcislo S, Rzepkowska-Misiak B et al.: Evaluation of the impact of radical resection of the tumor in patients with lung cancer at the level of activity of selected antioxidant enzymes. Kardiochir i T akochir Pol 2014; 11(4): 414-20.
  • 9. Van Kampen E, Zijlstra G: Standardization of hemoglobinometry. II. The hemiglobincyanide method. Clin Chim Acta 1961; 6: 538-44.
  • 10. Beers RF, Sizer W: A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952; 195: 133-40.
  • 11. Misra P, Fridovich J: The role of superoxide anion in the autooxidation of epinephrine and a simple assay for the superoxide dismutases. J Biol Chem 1972; 247: 3170-75.
  • 12. Salvemini F, Franze A, Iervolino A et al.: Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression J Biol Chem 1999; 274: 2750-57.
  • 13. Arai M, Imai H, Koumura T: Mitochondrial phospholipid hydroperoxide glutathione peroxidase plays a major role in preventing oxidative injury to cells. J Biol Chem 1999; 274: 4924-33.
  • 14. Flohe L: Glutathione peroxidase. Basic Life Sci 1988; 49: 663-68.
  • 15. Burk RF: Protection against free radical injury by selenoenzymes. Pharmacol Therap 1990; 45: 383-85.
  • 16. Dringer A: Metabolism and functions of glutathione in brain. Progress in Neurobiol 2000; 62: 649-71.
  • 17. Martin M, Macias M, Escames G et al.: Melatoin but not vitamin C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J 2000; 14 (12): 1677-79.
  • 18. Abdel-Aziz A F, El-Naggar mm: Superoxide dismutase activities in serum and white blood cells of patients with some malignancies. Cancer Lett 1997; 113(1-2): 61-64.
  • 19. Arivazhagan S et al.: Erythrocyte lipid peroxidation and antioxidants in gastric cancer patients. Cell Biochem Funct 1997; 15(1): 15-18.
  • 20. Crapo JD et al.: Copper, zinc superoxide dismutase is a primarily a cytosolic proein in human cells. Proc Natl Acad Sci USA 1992; 89: 10405-09.
  • 21. Hassan HM: Biosynthesis and regulation of superoxide dismutases. Free Radic Biol Med 1988; 5: 377-85.
  • 22. Izutani R, Asano S, Imano M et al.: Expression of manganese superoxide dismutase in esophageal and gastric cancers. J Gastroenterol 1998; 33(6): 816-22.
  • 23. Janssen AM, Bosman CB, Kruidenier L et al.: Superoxide dismutases in human colorectal cancer sequence. J Cancer Res Clin Oncol 1999; 125: 327-35.
  • 24. Janssen AM, Bosman CB, Van Duijn W et al.: Superoxide dismutases in gasric and esophageal cancer and prognosicimpact in gastric cancer. Clin Cancer Res 2000; 6(8): 3183-92.
  • 25. Malafa M, Margenthaler J, Webb B et al.: MnSOD expression is increased in metastatic gastric cancer. Surg Res 2000; 88(2): 130-34.
  • 26. Nelson RL : Superoxide dismutase in cultured benign and malignant tumors of the colon. Basic Life Sci 1988; 49: 699-702.
  • 27. Satomi A, Murakami S, Hashimoto T et al.: Significance of superoxide dismutase (SOD) in human colorecal cancer tissue: correlation with malignant intensity. J Gastroenterol 1995; 30(2): 177-82.
  • 28. Toh Y, Kuninaka S, Oshiro T et al.: Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. Int J Oncol 2000; 17(1): 107-12.
  • 29. Skrzycki M, Czeczot H: Rola dysmutazy ponadtlenkowej w powstawaniu nowotworów. Postępy Nauk Med 2005; 4: 7-15.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.